Browsing by Author Jean Marc Treluyer

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
1-Jan-2015Efavirenz concentrations and probability of HIV replication in childrenNontiya Homkham; Tim R. Cressey; Naïm Bouazza; Chulapong Chanta; Linda Aurpibul; Thition Narkbunnam; Sawitree Krikajornkitti; Nareerat Kamonpakorn; Marc Lallemant; Lily Ingsrisawang; Nicolas Salvadori; Jean Marc Treluyer; Saik Urien; Gonzague Jourdain
1-Jan-2015Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancyTim R. Cressey; Saik Urien; Edmund V. Capparelli; Brookie M. Best; Sudanee Buranabanjasatean; Aram Limtrakul; Boonsong Rawangban; Prapan Sabsanong; Jean Marc Treluyer; Gonzague Jourdain; Alice Stek; Marc Lallemant; Mark Mirochnick
1-Feb-2011Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected thai patients receiving indinavir boosted with ritonavirTim R. Cressey; Saik Urien; Deborah Hirt; Guttiga Halue; Malee Techapornroong; Chureeratana Bowonwatanuwong; Prattana Leenasirimakul; Jean Marc Treluyer; Gonzague Jourdain; Marc Lallemant
19-May-2015Modeling of in-utero and intra-partum transmissions to evaluate the efficacy of interventions for the prevention of perinatal HIVPatumrat Sripan; Sophie Le Coeur; Billy Amzal; Lily Ingsrisawang; Patrinee Traisathit; Nicole Ngo-Giang-Huong; Kenneth McIntosh; Tim R. Cressey; Suraphan Sangsawang; Boonsong Rawangban; Prateep Kanjanavikai; Jean Marc Treluyer; Gonzague Jourdain; Marc Lallemant; Saik Urien
1-Jan-2017Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patientsNaïm Bouazza; Tim R. Cressey; Frantz Foissac; Andrzej Bienczak; Paolo Denti; Helen McIlleron; David Burger; Martina Penazzato; Marc Lallemant; Edmund V. Capparelli; Jean Marc Treluyer; Saïk Urien
15-May-2008Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected childrenTim R. Cressey; Hannah Green; Saye Khoo; Jean Marc Treluyer; Alexandra Compagnucci; Yacine Saidi; Marc Lallemant; Diana M. Gibb; David M. Burger
1-Jan-2016A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based RegimensNontiya Homkham; Tim R. Cressey; Lily Ingsrisawang; Naïm Bouazza; Chaiwat Ngampiyaskul; Suchat Hongsiriwon; Sakulrat Srirojana; Suparat Kanjanavanit; Sorakij Bhakeecheep; Sophie Le Coeur; Nicolas Salvadori; Jean Marc Treluyer; Gonzague Jourdain; Saik Urien
1-May-2019Role of efavirenz plasma concentrations on long-term HIV suppression and immune restoration in HIV-infected childrenNontiya Homkham; Tim R. Cressey; Naim Bouazza; Lily Ingsrisawang; Pornchai Techakunakorn; Jutarat Mekmullica; Thitiporn Borkird; Achara Puangsombat; Sathaporn Na-Rajsima; Jean Marc Treluyer; Saik Urien; Gonzague Jourdain